GlassScriptPhysician profile
Alison N Gordon
NPI 1497072409
$2,897.75
in general payments reported to CMS, 2019-2025
15 companies · $932 in 2025
The $932 reported for 2025 was more than what 75% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $209 · 2020: $95.31 · 2021: $285 · 2022: $104 · 2023: $338 · 2024: $934 · 2025: $932.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,504 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,504.35 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $700.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,166.52 | 2019-2025 | Clareon, Centurion, Wavelight Ex500 Excimer Laser |
| Glaukos Corporation | $753.48 | 2024-2025 | Idosetr, Istent Infinite, Kxl System |
| Harrow Eye, LLC | $169.87 | 2024-2025 | Vevye |
| Allergan, INC. | $160.79 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $156.76 | 2023-2025 | Miebo, Xiidra, Vyzulta |
| Sun Pharmaceutical Industries INC. | $136.52 | 2019-2025 | Cequa |
| Tarsus Pharmaceuticals, INC. | $113.20 | 2024-2025 | Xdemvy |
| Novartis Pharmaceuticals Corporation | $62.51 | 2019 | |
| Oyster Point Pharma, INC. | $42.62 | 2022-2023 | Tyrvaya |
| Shire North American Group INC | $42.29 | 2019 | |
| Dompe US, INC. | $33.22 | 2025 | Oxervate |
| Mallinckrodt Hospital Products INC. | $19.43 | 2021 | |
| Aerie Pharmaceuticals, INC. | $19.22 | 2020 | |
| Biotissue Holdings INC. | $11.81 | 2019 | |
| Rxsight INC | $9.51 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alison Gordon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.